Wu et al. [41] found that kirenol (100–200 μg/mL) reduced the migration, invasion, and pro-inflammatory IL-6 secretion of rheumatoid arthritis (RA)-associated synovial fibroblasts (FLS). Here, IL6 is linked to rheumatoid arthritis.